Decentralized Manufacture

CELL AND GENE THERAPY INSIGHTS

Decentralized Manufacture

October 2019
Decentralized Manufacture
Download PDF

Research Article

Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption

Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption

Geoffrey Banda, Joyce Tait, James Mittra
23 October 2019
Read

Expert Insight

Decentralized manufacture of cell therapies: the challenge of operational modeling

Decentralized manufacture of cell therapies: the challenge of operational modeling

Nicholas Medcalf
23 October 2019
Read
Cell manufacturability

Cell manufacturability

Masahiro Kino-oka, Manabu Mizutani, Nicholas Medcalf
21 October 2019
Read
Implementation of advanced therapy medicinal products: a UK pharmacist’s perspective

Implementation of advanced therapy medicinal products: a UK pharmacist’s perspective

Anne Black
18 October 2019
Read
Regulatory considerations for decentralized manufacture of ATMPs

Regulatory considerations for decentralized manufacture of ATMPs

Alison Wilson, Alexis Cockroft
2 October 2019
Read
Decentralized manufacturing and institutional readiness: adoption as a distributed process

Decentralized manufacturing and institutional readiness: adoption as a distributed process

Andrew Webster
13 September 2019
Read

Interview

Building flexibility into GMP CAR T cell therapy manufacture

Building flexibility into GMP CAR T cell therapy manufacture

Christin Tischner
18 November 2019
Read
Challenges in demonstrating comparability in the decentralized manufacturing environment

Challenges in demonstrating comparability in the decentralized manufacturing environment

Jonathan Campbell
16 October 2019
Read
Pros and cons of point of care manufacture of cellular cancer immunotherapies

Pros and cons of point of care manufacture of cellular cancer immunotherapies

Linda Kelley
13 September 2019
Read

Webinars

Moving towards decentralized manufacturing of cell and gene therapy products through automation

Moving towards decentralized manufacturing of cell and gene therapy products through automation

I Johnston PhD, N Medcalf FREng FIChemE CChem CEng, Á Urbano-Ispizua PhD et al.
17 October 2019
Watch